Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency

RegulatoryThyroid Tablets, USP 30 mgNegative

AI Analysis

Summary

Vitruvias Therapeutics voluntarily recalled one lot of Thyroid Tablets USP 30 mg due to potential super potency. The recall affects Lot No. 504950 and is being conducted at the consumer level.

Outcome Details

Voluntary recall of one lot due to potential super potency

Importance:4/10

Sentiment:

-0.70

recallproduct_safetyregulatorymanufacturing

Related Companies

$HIT

Read the original article

Published by Drugs.com FDA MedWatch Alerts on August 21, 2026 1:50 PM

Read Original